Now showing items 1-3 of 3
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study.
BACKGROUND: Multimorbidity is a growing concern for healthcare systems, with many countries experiencing demographic transition to older population profiles. Chronic kidney disease (CKD) is common but often considered in ...
Skin autofluorescence and all-cause mortality in stage 3 CKD.
BACKGROUND AND OBJECTIVES: Novel markers may help to improve risk prediction in CKD. One potential candidate is tissue advanced glycation end product accumulation, a marker of cumulative metabolic stress, which can be ...